Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05960474 · ClinicalTrials.gov registry record
Coronary Microvascular Disease (CMD) Registry
A clinical trial of Coronary Microvascular Dysfunction, sponsored by Medstar Health Research Institute.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 3
- Study locations
NCT05960474: Recruiting study of Coronary Microvascular Dysfunction, sponsored by Medstar Health Research Institute.
NCT05960474 is a study of Coronary Microvascular Dysfunction that is actively recruiting participants, run by Medstar Health Research Institute. The registered enrollment target is 1,000 participants, above the 129-participant average among 7 other Coronary Microvascular Dysfunction trials with a reported enrollment target (675% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05960474, a study of Coronary Microvascular Dysfunction, is actively recruiting participants, sponsored by Medstar Health Research Institute.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this project is to provide appropriate administrative and technical supports for the warehousing and use of a database of patients with coronary microvascular disease (CMD). This protocol will outline the process for identification and capture of data, storage, as well as data use and sharing internally and externally for research purposes.
Conditions Studied
Interventions
- OTHER Outcomes for Patients with CMD
Study Locations (3)
District of Columbia
- Medstar Washington Hospital Center - Washington D.C.
Florida
- Memorial Regional Hospital - Hollywood
Maryland
- MedStar Southern Maryland - Clinton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2023-02-01 |
| Est. Completion | 2033-01 |
What NCT05960474 shows while recruiting
NCT05960474 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 129-participant average among 7 other Coronary Microvascular Dysfunction trials with a reported enrollment target (675% higher).
The record links to 1 condition, with Coronary Microvascular Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which Outcomes for Patients with CMD is the first listed.
NCT05960474 reports a single indexed study location in District of Columbia, Florida, Maryland.
Frequently Asked Questions
What is clinical trial NCT05960474 about?
NCT05960474 is a clinical study titled "Coronary Microvascular Disease (CMD) Registry". The purpose of this project is to provide appropriate administrative and technical supports for the warehousing and use of a database of patients with coronary microvascular disease (CMD). This protocol will outline the process for identification and capture of data, storage, as well as data use and...
What is the current status of trial NCT05960474?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2023-02-01. Estimated completion is 2033-01.
What conditions does trial NCT05960474 study?
This clinical trial studies the following conditions: Coronary Microvascular Dysfunction.
What interventions are being tested in trial NCT05960474?
The interventions under investigation include: Outcomes for Patients with CMD (OTHER).
Who is sponsoring clinical trial NCT05960474?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05960474 being conducted?
This trial has 3 study locations across District of Columbia, Florida, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Microvascular Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Coronary Vascular Health in Women
RECRUITING · Phase 2
-
Women's Ischemia Syndrome Evaluation (WISE) Pre-HFpEF
RECRUITING
-
A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD
RECRUITING
-
Assessment of Coronary Microvascular Dysfunction After STEMI Using Continuous Saline Thermodilution
RECRUITING
-
The DISCOVER INOCA Prospective Multi-center Registry
ACTIVE NOT RECRUITING
-
Safety and Potential Bioactivity of CLBS16 in Patients With Coronary Microvascular Dysfunction and Without Obstructive Coronary Artery Disease
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI